Accelerated Evolution and Molecular Surface of Venom Phospholipase A2 Enzymes

Abstract. Multiple phospholipase A2 (PLA2) isoenzymes found in a single snake venom induce a variety of pharmacological effects. These multiple forms are formed by gene duplication and accelerated evolution of exons. We examined the amino acid sequences of 127 snake venom PLA2 enzymes and their homologues to study in which location most natural substitutions occur. Our data show that hot spots of amino acid substitutions in this group of proteins occur mostly on the surface. A logistic model correlating the substitution rates of each amino acid residue with their surface accessibility indicates that the probability of natural substitutions occurring in the fully exposed residue is 2.6–3.5 times greater than that of substitutions occurring in buried residues. These surface substitutions play a significant role in the evolution of new PLA2 isoenzymes by altering the specificity of targeting to various tissues or cells, resulting in distinct pharmacological effects. Thus natural substitutions in PLA2 enzymes, in contrast to popular belief, are not random substitutions but appear to be directed toward modifying the molecular surface.

[1]  R. Heinrikson,et al.  Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. , 1977, The Journal of biological chemistry.

[2]  A. Goldstein,et al.  Purification and properties , 1975 .

[3]  M. Hattori,et al.  Accelerated evolution in the protein-coding regions is universal in crotalinae snake venom gland phospholipase A2 isozyme genes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J I Salach,et al.  Phospholipase A of snake venoms. I. Isolation and molecular properties of isoenzymes from Naja naja and Vipera russellii venoms. , 1971, The Journal of biological chemistry.

[5]  J. Daltry,et al.  Diet and snake venom evolution , 1996, Nature.

[6]  P. Sigler,et al.  Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. , 1990, Science.

[7]  M. Kimura.  Evolutionary Rate at the Molecular Level , 1968, Nature.

[8]  Y. Shimohigashi,et al.  Accelerated evolution of crotalinae snake venom gland serine proteases , 1996, FEBS letters.

[9]  R. Kini,et al.  Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. , 1987, Toxicon : official journal of the International Society on Toxinology.

[10]  J. Overbaugh,et al.  The origin of mutants , 1988, Nature.

[11]  C. Yen,et al.  Identification of a new binding protein for crotoxin and other neurotoxic phospholipase A2s on brain synaptic membranes. , 1991, Biochemistry.

[12]  C. Takasaki,et al.  Amino acid sequences of eight phospholipases A2 from the venom of Australian king brown snake, Pseudechis australis. , 1990, Toxicon : official journal of the International Society on Toxinology.

[13]  P. Rosenberg.  What is the relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons , 1985 .

[14]  M. Hattori,et al.  Accelerated evolution of Trimeresurus flavoviridis venom gland phospholipase A2 isozymes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  BEATRIZ M. BRAGANCA,et al.  Multiple Forms of Cobra Venom Phospholipase A , 1967, Nature.

[16]  C. Bon.  Synergism of the two subunits of crotoxin. , 1982, Toxicon : official journal of the International Society on Toxinology.

[17]  Flavio Toma,et al.  Structural basis for functional diversity of animal toxins , 1992 .

[18]  W. L. Payne,et al.  High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens , 1996, Science.

[19]  J. Richards.  The structure and action of proteins , 1969 .

[20]  T. Tsujita.  [Phospholipase A]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[21]  R. Miledi,et al.  Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. , 1977, European journal of biochemistry.

[22]  M. Gelb,et al.  Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue , 1990, Science.

[23]  B. Hall,et al.  Spontaneous point mutations that occur more often when advantageous than when neutral. , 1990, Genetics.

[24]  R. Kini,et al.  Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2. , 1987, The Journal of biological chemistry.

[25]  J. Harris.  Phospholipases in snake venoms and their effects on nerve and muscle. , 1985, Pharmacology & therapeutics.

[26]  Andrew J. Leigh Brown.  Positively darwinian molecules? , 1987, Nature.

[27]  D. Richman,et al.  HIV-1: Gambling on the evolution of drug resistance? , 1997, Nature Medicine.

[28]  T. Creighton,et al.  Functional evolutionary divergence of proteolytic enzymes and their inhibitors. , 1989, Trends in biochemical sciences.

[29]  P B Sigler,et al.  The refined crystal structure of dimeric phospholipase A2 at 2.5 A. Access to a shielded catalytic center. , 1986 .

[30]  I. Kato,et al.  Positive darwinian selection in evolution of protein inhibitors of serine proteinases. , 1987, Cold Spring Harbor symposia on quantitative biology.

[31]  N. Tamiya,et al.  Purification and properties of several phospholipases A2 from the venom of Australian king brown snake (Pseudechis australis). , 1990, Toxicon : official journal of the International Society on Toxinology.

[32]  W. Brown,et al.  Structural biology and phylogenetic estimation , 1997, Nature.

[33]  J. Dolly,et al.  Identification of the neuronal acceptor in bovine cortex for ammodytoxin C, a presynaptically neurotoxic phospholipase A2. , 1994, Biochemistry.

[34]  R. Kini,et al.  The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. , 1990, Biochemistry.

[35]  R. Kini,et al.  A model to explain the pharmacological effects of snake venom phospholipases A2. , 1989, Toxicon : official journal of the International Society on Toxinology.

[36]  T. V. Gowda,et al.  Geographical variation in India in the composition and lethal potency of Russell's viper (Vipera russelli) venom. , 1988, Toxicon : official journal of the International Society on Toxinology.

[37]  M. Lazdunski,et al.  Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. , 1989, The Journal of biological chemistry.

[38]  M. L. Connolly.  Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.

[39]  M. Hattori,et al.  Unusually high conservation of untranslated sequences in cDNAs for Trimeresurus flavoviridis phospholipase A2 isozymes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Tu.  Venoms: Chemistry and molecular biology , 1977 .

[41]  Y. Sakaki,et al.  Accelerated evolution of Trimeresurus okinavensis venom gland phospholipase A2 isozyme-encoding genes. , 1996, Gene.

[42]  C. C. Viljoen,et al.  Bitis gabonica venom. The amino acid sequence of phospholipase A. , 1974, The Journal of biological chemistry.

[43]  A. Agresti.  An introduction to categorical data analysis , 1997 .

[44]  C. Yang,et al.  Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2. , 1981, Toxicon : official journal of the International Society on Toxinology.

[45]  Nicholas D. Hastie,et al.  Accelerated evolution in the reactive centre regions of serine protease inhibitors , 1987, Nature.